BioMarin Pharmaceutical, Inc. (BMRN)
55.26
-0.21
(-0.38%)
USD |
NASDAQ |
Apr 15, 16:00
55.26
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap : 10.63B for April 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.537B |
| Ionis Pharmaceuticals, Inc. | 12.69B |
| Mirum Pharmaceuticals, Inc. | 5.818B |
| Hims & Hers Health, Inc. | 5.557B |
| ACADIA Pharmaceuticals, Inc. | 3.712B |
Market Cap Related Metrics
| PE Ratio | 31.02 |
| PS Ratio | 3.315 |
| Price to Book Value | 1.746 |
| Price to Free Cash Flow | 14.99 |
| Price | 55.26 |
| Earnings Yield | 3.22% |
| Operating PE Ratio | 13.15 |
| Normalized PE Ratio | 17.35 |